Markets:

Overview

News

Currencies

International

Treasuries

Pfizer (NY:PFE)

25.28 -0.15 (-0.59%)

Official Closing Price Updated: 7:00 PM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

99 100 Next >

Thursday's session: most active stock in the S&P500 index ↗

October 30, 2025

Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Thursday and uncover the stocks that are leading the way in terms of trading volume and market...

Via Chartmill

Check out the stocks that are attracting the most attention and driving market activity. ↗

October 30, 2025

Let's dive into the action on the US markets on Thursday. Here are the most active stocks that are driving the market today.

Via Chartmill

Novo Nordisk Kicks Off Bloody Battle With Pfizer, Bidding $6.5 Billion On Metsera ↗

October 30, 2025

Novo Nordisk kicked off a battle with Pfizer on Thursday, making an unsolicited $6.5 billion bid for obesity-focused Metsera.

Via Investor's Business Daily

Topics Economy Government

Retail Investors Now Expect Viking Therapeutics To Bag A Deal After Novo Nordisk, Pfizer Engage In A Bidding War For Rival Metsera ↗

October 30, 2025

Via Stocktwits

Novo Nordisk Submits Revised Bid For Metsera, Enters A Bidding War With Pfizer ↗

October 30, 2025

Via Stocktwits

Pfizer Blasts Novo Nordisk's $9 Billion Counteroffer For Metsera As 'Reckless' ↗

October 30, 2025

Novo Nordisk's $9 billion offer for Metsera challenges Pfizer's existing merger deal, prompting sharp criticism and potential legal action.

Via Benzinga

Alnylam Stock Has Already Doubled In 2025. Why It Could Rocket Again On Earnings. ↗

October 30, 2025

The company easily beat third-quarter expectations and issued guidance that widely topped forecasts.

Via Investor's Business Daily

Pfizer Addresses Proposal for Metsera

October 30, 2025

From Pfizer Inc.

Via Business Wire

Prediction: Putting $1,000 Into These Dividend Stocks Could Pay Off for Years ↗

October 30, 2025

Investing in high-quality stocks with generous dividend payouts can help you gradually build substantial wealth.

Via The Motley Fool

2 High-Yield Stocks With Fresh Catalysts ↗

October 29, 2025

Income investors can capture yields above 5% from companies executing business transformations.

Via The Motley Fool

Topics Lawsuit

S&P 500 Healthcare Sector Navigates Mixed Market Waters on October 29, 2025

October 29, 2025

On October 29, 2025, the broader market exhibited a decidedly mixed performance, reflecting a prevailing sense of uncertainty among investors. Against this backdrop of fluctuating sentiment, the S&P...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

'I Still Can't Believe It's Around': Cramer Rips Plug Power ↗

October 29, 2025

Mad Money Lightning Round: Jim Cramer says Sempra (SRE) is a buy, supported by Wells Fargo's Overweight rating. Pfizer (PFE) and Dow (DOW) discussed. Plug Power (PLUG) faces concerns over shareholder...

Via Benzinga

Topics Stocks

1 S&P 500 Stock to Target This Week and 2 We Brush Off

October 29, 2025

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth,...

Via StockStory

Topics Stocks

Ken Paxton Alleges Johnson & Johnson Misled Mothers On Tylenol Safety ↗

October 28, 2025

Texas Attorney General Ken Paxton sued Johnson & Johnson and Kenvue, alleging Tylenol was deceptively marketed as safe for pregnant women.

Via Benzinga

Topics Lawsuit

Why NeoGenomics (NEO) Stock Is Trading Up Today

October 28, 2025

Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) jumped 1.1% in the morning session after it reported third-quarter 2025 results where revenue beat Wall Street's expectations.

Via StockStory

Topics World Trade

Healthcare Sector Navigates Volatile Waters as S&P 500 Closes: A Deep Dive into Key Market Drivers

October 27, 2025

As the closing bell rings on October 27, 2025, the S&P 500 Healthcare sector stands at a critical juncture, exhibiting the nuanced volatility that defines this essential yet complex segment of the...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

3 Dividend-Paying Drug Stocks to Buy at a Discount ↗

October 27, 2025

Some of the largest drugmakers in the world are trading at attractive valuations. Are they worth buying?

Via The Motley Fool

Topics Intellectual Property

What Is 1 of the Best Pharmaceutical Stocks to Buy Now? ↗

October 27, 2025

This pharma giant is entering the rapidly expanding market for weight loss drugs.

Via The Motley Fool

Should You Buy Pfizer Stock Before Nov. 4? ↗

October 27, 2025

The pharma giant is slated to report its latest quarterly numbers next week.

Via The Motley Fool

Topics Government Intellectual Property World Trade

Dow Jones Soars to New Record High Amidst Wave of Optimism, Signaling Robust Market Confidence

October 27, 2025

The Dow Jones Industrial Average (DJIA) recently achieved a significant milestone, surging by over 200 points to close at an unprecedented all-time record high in October 2025. This remarkable ascent...

Via MarketMinute

Topics Artificial Intelligence Economy Energy

Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology

October 27, 2025

Via Investor Brand Network

Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology

October 27, 2025

EQNX::TICKER_START (OTCQB:OTLC),(NASDAQ:IOBT),(NYSE:NVS),(NASDAQ:BCAX),(NYSE:PFE) EQNX::TICKER_END

Via FinancialNewsMedia

2 Unstoppable Health Care Giants to Buy Right Now for Less Than $1,000 ↗

October 27, 2025

These two healthcare giants are doing what they need to do to get their businesses rocking and rolling again.

Via The Motley Fool

Topics Intellectual Property World Trade

Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030 ↗

October 27, 2025

Vertex appears to be by far the better buy right now.

Via The Motley Fool

Topics Intellectual Property

3 Healthcare Stocks Paying the Highest Dividends of 2025 ↗

October 27, 2025

If you are looking for high yields in the healthcare sector, here are three choices. Make sure you understand the risks before you buy them.

Via The Motley Fool

Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever. ↗

October 26, 2025

Looking at high-yield healthcare stocks? These three stand out (but one has a slight skew to its story).

Via The Motley Fool

Topics Government

2 Unstoppable Dividend Stocks Yielding More Than 4% That Income-Seeking Investors Will Want to Buy in November and Hold Forever ↗

October 25, 2025

Both companies are monsters in their industry and are poised to thrive.

Via The Motley Fool

Topics Government Intellectual Property World Trade

What Occidental Petroleum’s Latest Backer Sees in Oil’s Next Chapter ↗

October 24, 2025

What Occidental Petroleum’s Latest Backer Sees in Oil’s Next Chapter

Via The Motley Fool

Topics Energy Regulatory Compliance

Inhibrx Stock Soars on Breakthrough Chondrosarcoma Trial Results: A New Dawn for Rare Cancer Treatment

October 24, 2025

San Diego, CA – October 24, 2025 – Inhibrx (NASDAQ: INBX) shares have surged dramatically, skyrocketing over 70% in pre-market and after-hours trading, following the announcement of overwhelmingly...

Via MarketMinute

Sanofi Soars as Dupixent Sales Near €5 Billion Amidst Intensifying Trump Drug Pricing Negotiations

October 24, 2025

Paris, France – October 24, 2025 – Pharmaceutical giant Sanofi (EURONEXT: SAN, NASDAQ: SNY) saw its shares climb today following the announcement of stellar third-quarter 2025 financial results,...

Via MarketMinute

Topics Government World Trade

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.